品牌 | 货号 | 包装单位 | 货期 | CAS | 产品名称 | 质量规格 | 单价(¥) | 购买数量 |
---|---|---|---|---|---|---|---|---|
阿拉丁 | G125821-10mg | 10mg | 期货,请咨询 | 196808-24-9 |
GW1929,PPARγ激动剂 GW1929 |
Moligand™, ≥98% |
|
|
阿拉丁 | G125821-50mg | 50mg | 期货,请咨询 | 196808-24-9 |
GW1929,PPARγ激动剂 GW1929 |
Moligand™, ≥98% |
|
|
阿拉丁 | G125821-5mg | 5mg | 期货,请咨询 | 196808-24-9 |
GW1929,PPARγ激动剂 GW1929 |
Moligand™, ≥98% |
|
|
阿拉丁 | G125821-100mg | 100mg | 期货,请咨询 | 196808-24-9 |
GW1929,PPARγ激动剂 GW1929 |
Moligand™, ≥98% |
|
|
阿拉丁 | G125821-25mg | 25mg | 期货,请咨询 | 196808-24-9 |
GW1929,PPARγ激动剂 GW1929 |
Moligand™, ≥98% |
|
|
毕得 | BD132494-25mg | 25mg | 现货 | 196808-24-9 |
(S)-2-((2-苯甲酰基苯基)氨基)-3-(4-(2... (S)-2-((2-Benzoylphenyl)amin... |
99% |
|
|
毕得 | BD132494-10mg | 10mg | 现货 | 196808-24-9 |
(S)-2-((2-苯甲酰基苯基)氨基)-3-(4-(2... (S)-2-((2-Benzoylphenyl)amin... |
99% |
|
|
毕得 | BD132494-50mg | 50mg | 现货 | 196808-24-9 |
(S)-2-((2-苯甲酰基苯基)氨基)-3-(4-(2... (S)-2-((2-Benzoylphenyl)amin... |
99% |
|
|
毕得 | BD132494-100mg | 100mg | 现货 | 196808-24-9 |
(S)-2-((2-苯甲酰基苯基)氨基)-3-(4-(2... (S)-2-((2-Benzoylphenyl)amin... |
99% |
|
|
罗恩 | R053806-10mg | 10mg | 现货 | 196808-24-9 |
GW1929 GW1929 |
≥99% |
|
|
罗恩 | R053806-5mg | 5mg | 现货 | 196808-24-9 |
GW1929 GW1929 |
≥99% |
|
|
国药沃凯 | XW0119680824902 | 10mg | 现货 | 196808-24-9 |
试剂GW1929 (储存“2-8℃”;运输“冰袋”) GW1929? |
≥99%(沃凯) |
|
|
国药沃凯 | XW0119680824901 | 5mg | 现货 | 196808-24-9 |
试剂GW1929 (储存“2-8℃”;运输“冰袋”) GW1929? |
≥99%(沃凯) |
|
|
麦克林2025 | G880826-5mg | 5mg | >10 | 196808-24-9 |
GW1929 GW1929 |
≥99% |
|
|
麦克林2025 | G880826-10mg | 10mg | 2.000 | 196808-24-9 |
GW1929 GW1929 |
≥99% |
|
|
源叶 | S84239-5mg | 5mg | 期货,请咨询 | 196808-24-9 |
GW1929 GW1929 |
99% |
|
|
源叶 | S84239-10mg | 10mg | 期货,请咨询 | 196808-24-9 |
GW1929 GW1929 |
99% |
|
|
源叶 | S84239-25mg | 25mg | 期货,请咨询 | 196808-24-9 |
GW1929 GW1929 |
99% |
|
|
源叶 | S84239-50mg | 50mg | 期货,请咨询 | 196808-24-9 |
GW1929 GW1929 |
99% |
|
|